Primary outcome was obliteration or absence of the treated GSV segment ; secondary outcomes were absence of GSV reflux , and change in Chronic Venous Insufficiency quality-of-life Questionnaire ( CIVIQ ) and EuroQol - 5D ( EQ-5D ) scores .